Effect of Topical and Oral Diclofenac on Pain Related to Intravitreal Injections
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The analgestic efffect of Diclofenac Sodium 0.1% Eye Drops and a combination of Diclofenac
Sodium 0.1% Eye Drops and oral Diclofenac Sodium sustained-release 75mg tablets on pain
related to intravitreal injections will be evalutated.
Pain perception will be assessed by the Short Form of the McGill Pain Questionnaire.